Yeah, I get that idea, just cant see it for a limited study in mouse models. Surely that sort of advantage is evident only when you are delivering quantities at the scale required for human deployment? Anyway, if it proves to show up this easily, then perhaps it could be due to that.
- Forums
- ASX - By Stock
- CYP
- Ann: CYP MSC Data in Asthma Model Published in Sceintific Journal
CYP
cynata therapeutics limited
Add to My Watchlist
3.23%
!
16.0¢

Ann: CYP MSC Data in Asthma Model Published in Sceintific Journal, page-6
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
16.0¢ |
Change
0.005(3.23%) |
Mkt cap ! $36.15M |
Open | High | Low | Value | Volume |
16.0¢ | 16.0¢ | 16.0¢ | $11.15K | 69.69K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 70000 | 15.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
16.0¢ | 305 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 70000 | 0.155 |
9 | 230624 | 0.150 |
2 | 105000 | 0.145 |
4 | 530785 | 0.140 |
1 | 2500 | 0.135 |
Price($) | Vol. | No. |
---|---|---|
0.160 | 305 | 1 |
0.165 | 1713 | 1 |
0.170 | 129998 | 2 |
0.180 | 43250 | 1 |
0.185 | 35990 | 1 |
Last trade - 13.17pm 04/07/2025 (20 minute delay) ? |
Featured News
CYP (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online